KYMR
Kymera Therapeutics Inc
$45.4
Earnings Summary
Revenue | $25.65Mn |
Net Profits | $-42.06Mn |
Net Profit Margins | -163.98% |
Highlights
Kymera Therapeutics Inc’s revenue jumped 55.33% since last year same period to $25.65Mn in the Q2 2024. On a quarterly growth basis, Kymera Therapeutics Inc has generated 149.34% jump in its revenue since last 3-months.
Kymera Therapeutics Inc’s net profit fell -8.41% since last year same period to $-42.06Mn in the Q2 2024. On a quarterly growth basis, Kymera Therapeutics Inc has generated 13.38% jump in its net profits since last 3-months.
Kymera Therapeutics Inc’s net profit margin jumped 30.21% since last year same period to -163.98% in the Q2 2024. On a quarterly growth basis, Kymera Therapeutics Inc has generated 65.26% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Kymera Therapeutics Inc post its latest quarter earnings
EPS Estimate Current Year | -0.73 |
Highlights
Kymera Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.73.
Key Ratios
Key ratios of the Kymera Therapeutics Inc post its Q2 2024 earnings
Earning Per Share (EPS) | -0.58 |
Highlights
Kymera Therapeutics Inc’s earning per share (EPS) jumped 13.43% since last year same period to -0.58 in the Q2 2024. This indicates that the Kymera Therapeutics Inc has generated 13.43% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-05-02 | -0.73 | -0.62 | 15.07% |
2024-08-07 | -0.68 | -0.58 | 14.71% |
₹0 US Stocks a/c Opening Fee